These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 99046)

  • 21. Treatment of hyaline membrane disease by human amniotic fluid surfactant.
    Jin HZ; Chen C; Jin QL; Shao XM
    Chin Med J (Engl); 1989 Dec; 102(12):944-6. PubMed ID: 2517741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Morphofunctional state of the APUD-system cells of the lungs in hyaline membrane disease of newborn infants].
    Bubnova NI
    Arkh Patol; 1987; 49(8):47-52. PubMed ID: 2890337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathology of neonatal surfactant deficiency.
    Robertson B
    Perspect Pediatr Pathol; 1987; 11():6-46. PubMed ID: 3110733
    [No Abstract]   [Full Text] [Related]  

  • 24. Pulmonary yellow hyaline membrane disease. New variant in premature infants with intrahepatic cholestasis.
    Cho SY; Sastre M
    Arch Pathol Lab Med; 1976 Mar; 100(3):145-6. PubMed ID: 946401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of surfactant and antenatal corticosteroid treatment on the pulmonary pathology of preterm infants with respiratory distress syndrome.
    Teksam O; Kale G
    Pathol Res Pract; 2009; 205(1):35-41. PubMed ID: 18951732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short term morphologic effects of high ambient levels of ozone on lungs of rhesus monkeys.
    Mellick PW; Dungworth DL; Schwartz LW; Tyler WS
    Lab Invest; 1977 Jan; 36(1):82-90. PubMed ID: 401528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Normal and pathological anatomy of the lung in premature babies and in the so-called "hyaline membrane disease"].
    Lauweryns JM
    Verh K Vlaam Acad Geneeskd Belg; 1972; 34(3):233-339. PubMed ID: 4605817
    [No Abstract]   [Full Text] [Related]  

  • 28. Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease.
    Gitlin JD; Soll RF; Parad RB; Horbar JD; Feldman HA; Lucey JF; Taeusch HW
    Pediatrics; 1987 Jan; 79(1):31-7. PubMed ID: 3540835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surfactant quantity and composition during recovery from hyaline membrane disease.
    Jackson JC; Palmer S; Truog WE; Standaert TA; Murphy JH; Hodson WA
    Pediatr Res; 1986 Dec; 20(12):1243-7. PubMed ID: 3642428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of exogenous surfactant on the development of bronchopulmonary dysplasia in a baboon hyaline membrane disease model.
    Maeta H; Raju TN; Vidyasagar D; Bhat R; Esterly J; Matsuda H; Shimada S; Krukenkamp IB; Shanklin DR
    Crit Care Med; 1990 Apr; 18(4):403-9. PubMed ID: 2318051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pulmonary hyaline membranes in newborn infants. (Idiopathic respiratory distress syndrome)].
    Göcke H; Bienengräber A
    Zentralbl Chir; 1974 Aug; 99(34):1057-61. PubMed ID: 4613061
    [No Abstract]   [Full Text] [Related]  

  • 32. Surfactant replacement therapy in newborns with hyaline membrane disease.
    Grobman DW; Foley MM
    Crit Care Nurs Clin North Am; 1992 Sep; 4(3):515-20. PubMed ID: 1388997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevention of hyaline membrane disease: new concepts and approaches to therapy.
    Farrell PM; Kotas RV
    Adv Pediatr; 1976; 23():213-69. PubMed ID: 795280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphogenetic and functional activity of type II cells in early fetal rhesus monkey lungs. A comparison between primates and rodents.
    Ten Have-Opbroek AA; Plopper CG
    Anat Rec; 1992 Sep; 234(1):93-104. PubMed ID: 1416101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perspectives on respiratory distress syndrome of the newborn.
    Polak MJ; Polak JD; Bucciarelli RL
    Compr Ther; 1989 Dec; 15(12):28-34. PubMed ID: 2691189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perinatal reactions of the rabbit lung to maternal endotoxemia.
    Balis JU; Pagast P; McKeever L; Shelley S
    Lab Invest; 1975 Sep; 33(3):289-97. PubMed ID: 1099338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [High frequency oscillation ventilation after surfactant use in hyaline membrane disease. Outcome of ventilation parameters].
    Claris O; Lapillonne A; Madinier-Chappat N; Miguet D; Salle BL
    Cah Anesthesiol; 1994; 42(3):325-8. PubMed ID: 7812856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The pathogenesis and morphogenesis of noninflammatory lung diseases in premature infants].
    Bubnova NI
    Vestn Akad Med Nauk SSSR; 1990; (5):34-6. PubMed ID: 2389600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunocytochemical localization of epidermal growth factor in the developing human respiratory system and in acute and chronic lung disease in the neonate.
    Stahlman MT; Orth DN; Gray ME
    Lab Invest; 1989 Apr; 60(4):539-47. PubMed ID: 2785233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surfactant treatment in experimental hyaline membrane disease.
    Nilsson R; Grossmann G; Berggren P; Robertson B
    Eur J Respir Dis; 1981 Dec; 62(6):441-9. PubMed ID: 6922790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.